ESC Premium Access

Increasing use of NOAC and antiplatelet combination therapy in atrial fibrillation following myocardial infarction or percutaneous coronary intervention

Congress Session

About the speaker

Ms Caroline Sindet-Pedersen

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)
0 follower

7 more presentations in this session

Association between sociodemographic factors and choice of Direct Oral Anticoagulants versus warfarin in atrial fibrillation: A population based cross-sectional study using Swedish Registers

Speaker: Mr G. Brobert (Solna, SE)

Thumbnail

Favorable effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with liver cirrhosis

Speaker: Doctor H. Yu (Seoul, KR)

Thumbnail

Non-vitamin K antagonist oral anticoagulants in comparison to phenprocoumon in a real-word setting of atrial fibrillation: an analysis of a large german health claims dataset

Speaker: Mr C. Hohmann (Cologne, DE)

Thumbnail

Dabigatran-induced esophagitis after radiofrequency catheter ablation

Speaker: Doctor Y. Ito (Tsukuba, JP)

Thumbnail

Epicardial application of amiodarone-releasing hydrogel: experimental study

Speaker: Professor O. Bockeria (Moscow, RU)

Thumbnail

Access the full session

Drug treatment in patients with arrhythmia

Speakers: Ms C. Sindet-Pedersen, Mr G. Brobert, Doctor H. Yu, Mr C. Hohmann, Doctor Y. Ito...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk